Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Leprosy Reaction

Understanding Immune Flare-Ups: Leprosy Reactions

At a Glance

A leprosy reaction is an immune system flare-up against dying bacteria during Hansen's disease treatment, not a sign your medication is failing. Do not stop your antibiotics. Contact your doctor immediately if you develop painful skin patches, new red bumps, high fever, or sudden nerve weakness.

As you undergo treatment for Hansen’s disease, you may experience what doctors call a leprosy reaction. It is vital to understand that a reaction is not a sign that your medication is failing or that the disease is getting worse [1]. Instead, it is your immune system waking up and “cleaning house” as it reacts to the dead or dying bacteria in your body [2].

Think of it like a controlled burn: it is uncomfortable and needs management, but it is part of the process of clearing the infection.

CRITICAL RULE: Do Not Stop Your Antibiotics

If you experience a reaction, do not stop taking your multidrug therapy (MDT) antibiotics unless explicitly directed by your doctor [2]. A reaction means your immune system is fighting the dead bacteria, not that the antibiotics are making you sicker. Stopping your antibiotics can disrupt your cure [3].

Types of Reactions

There are two main types of immune reactions that occur in Hansen’s disease.

Type 1: The Reversal Reaction

This usually happens to patients in the “borderline” or “tuberculoid” part of the spectrum [2]. It is caused by your immune cells suddenly rushing to the skin and nerves to attack the bacteria [4].

  • What it looks like: Your existing skin patches suddenly become red, swollen, and tender [5].
  • The danger: This reaction often involves the nerves. You may notice sudden new numbness or weakness in your hands or feet [6].
  • Treatment: The standard treatment is corticosteroids (like prednisolone) to calm the inflammation and protect the nerves from permanent damage [6][7].

Type 2: Erythema Nodosum Leprosum (ENL)

This reaction is more common in patients with a higher bacterial load (the “multibacillary” or “lepromatous” pole) [8]. It is a reaction where clusters of antibodies overreact and latch onto pieces of dead bacteria in the bloodstream [8][9].

  • What it looks like: You may develop crops of painful, red nodules (bumps) under the skin, especially on the arms and legs [8][10]. These bumps often come and go and are accompanied by high-grade fever and general malaise [11][12].
  • Treatment: ENL is often managed with a combination of steroids, clofazimine, and a specialized medication called Thalidomide [3][13].

Understanding Thalidomide

Thalidomide is highly effective at “turning off” the severe inflammation of ENL [14]. However, because of its history and biological power, it is one of the most strictly regulated drugs in the world [15].

  • Extreme Pregnancy Risk: Thalidomide is a known teratogen, meaning it causes severe, life-altering birth defects even if only a single dose is taken during pregnancy [16][17].
  • The S.T.E.P.S. Program: In the U.S., you can only receive Thalidomide through a mandatory program. This requires regular pregnancy tests and the use of two forms of highly effective birth control for anyone who could become pregnant [18][19].
  • Nerve Monitoring: While Thalidomide treats the reaction, it can sometimes cause its own form of nerve damage (peripheral neuropathy). Your doctor will monitor you closely for any new tingling or “pins and needles” sensations [20][21].

When to Call Your Doctor

Because reactions can lead to permanent nerve damage if they aren’t treated quickly, you should contact your care team immediately if you notice [11][6]:

  • Skin patches that were quiet but are now red, hot, or painful.
  • New painful bumps under the skin.
  • Sudden weakness (like a “floppy” foot or a weak grip).
  • A high fever that wasn’t there before.

Treatment for reactions can sometimes last for months, even after your original antibiotic course is finished. Patience and close communication with your doctor are key to a successful recovery [3][22].

Common questions in this guide

Is a leprosy reaction a sign that my antibiotics aren't working?
No. A reaction means your immune system is waking up and attacking the dead or dying bacteria. It is a normal part of the healing process, and you should never stop taking your multidrug therapy antibiotics unless your doctor explicitly tells you to.
What are the symptoms of a Type 1 reversal reaction?
During a Type 1 reaction, your existing skin patches may suddenly become red, swollen, and tender. You might also notice sudden numbness or weakness in your hands or feet, which requires immediate medical attention to prevent permanent nerve damage.
What is Erythema Nodosum Leprosum (ENL)?
ENL is a Type 2 leprosy reaction where painful, red bumps develop under the skin, usually on the arms and legs. It is often accompanied by a high fever and a general feeling of being unwell.
Why is Thalidomide used to treat leprosy reactions?
Thalidomide is highly effective at stopping the severe inflammation associated with Type 2 (ENL) leprosy reactions. However, because it can cause severe birth defects, it is heavily regulated and requires strict birth control and regular pregnancy testing.
When should I contact my doctor about a leprosy reaction?
Call your doctor immediately if your skin patches become hot and painful, you develop new painful bumps under the skin, you have a new high fever, or you experience sudden weakness or numbness in your hands or feet.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I experiencing a Type 1 'reversal reaction' or a Type 2 'ENL reaction'?
  2. 2.How can we be sure this is an immune reaction and not the disease getting worse or a relapse?
  3. 3.What is the plan for tapering my steroids? How will we monitor for side effects like weight gain or high blood sugar?
  4. 4.If I need to start Thalidomide, what are the exact requirements of the S.T.E.P.S. program for me?
  5. 5.How will we monitor my nerve function during this reaction to prevent permanent damage?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Morphological Index as a Sensitive Marker of Drug Resistance in Leprosy: A Case Series.

    Chhabra N, Kumar TS, Singh I, Ganguly S

    Indian journal of dermatology 2024; (69(2)):202 doi:10.4103/ijd.ijd_781_23.

    PMID: 38841236
  2. 2

    Leprosy reactions: Unraveling immunological mechanisms underlying tissue damage in leprosy patients.

    Serrano-Coll H, Wan EL, Restrepo-Rivera L, Cardona-Castro N

    Pathogens and disease 2024; (82()) doi:10.1093/femspd/ftae013.

    PMID: 38806255
  3. 3

    Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 lepra reaction: report on three cases.

    Rahul N, Sanjay KS, Singh S

    Leprosy review 2015; (86(4)):379-82.

    PMID: 26964434
  4. 4

    Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators.

    Silva CA, Webb K, Andre BG, et al.

    The Journal of infectious diseases 2017; (215(3)):431-439 doi:10.1093/infdis/jiw541.

    PMID: 27932613
  5. 5

    Neutrophils in Leprosy.

    Schmitz V, Tavares IF, Pignataro P, et al.

    Frontiers in immunology 2019; (10()):495 doi:10.3389/fimmu.2019.00495.

    PMID: 30949168
  6. 6

    Corticosteroids for treating nerve damage in leprosy.

    Van Veen NH, Nicholls PG, Smith WC, Richardus JH

    The Cochrane database of systematic reviews 2016; CD005491 doi:10.1002/14651858.CD005491.pub3.

    PMID: 27210895
  7. 7

    Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial.

    Wagenaar I, Post E, Brandsma W, et al.

    PLoS neglected tropical diseases 2017; (11(10)):e0005952 doi:10.1371/journal.pntd.0005952.

    PMID: 28976976
  8. 8

    Painful bullae in a febrile woman: a clue to first presentation of multibacillary Hansen's disease.

    Laishram R, Sophia M, Hazarika N

    BMJ case reports 2022; (15(5)) doi:10.1136/bcr-2022-250269.

    PMID: 35618339
  9. 9

    Current Concepts and Challenges in the Management of Erythema Nodosum Leprosum.

    Singal A

    Indian dermatology online journal 2020; (11(4)):479-481 doi:10.4103/idoj.IDOJ_69_20.

    PMID: 32832432
  10. 10

    Title not available

    Alakad R, Nofal A, Assaf M

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2021; (19(8)):1133-1144 doi:10.1111/ddg.14449_g.

    PMID: 34390149
  11. 11

    Lichenoid Skin Nodules as Presenting Feature of Necrotic Erythema Nodosum Leprosum in Leprosy.

    Kaushik A, Dogra S, Narang T

    The American journal of tropical medicine and hygiene 2020; (103(1)):9.

    PMID: 32653048
  12. 12

    Neutrophilic leukocytosis and erythema nodosum leprosum in leprosy: insights from a retrospective observational study.

    Feitosa da Silva Barboza M, de Andrea Hacker M, Maria Sales A, et al.

    Frontiers in immunology 2024; (15()):1368460 doi:10.3389/fimmu.2024.1368460.

    PMID: 39072336
  13. 13

    A Case of Lepromatous Leprosy With Erythema Nodosum Leprosum.

    Park L, Wallace CE, Vasile G, Buckley C

    Cureus 2023; (15(1)):e33846 doi:10.7759/cureus.33846.

    PMID: 36819324
  14. 14

    A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.

    Bathula S, Sardana K, Mathachan SR, et al.

    International journal of dermatology 2023; (62(1)):48-55 doi:10.1111/ijd.16315.

    PMID: 35924464
  15. 15

    Involvement of the nitric oxide pathway in the anti-depressant-like effects of thalidomide in mice.

    Rostamian A, Gharedaghi A, Norouzi-Javidan A, Dehpour AR

    Physiology & behavior 2019; (208()):112572 doi:10.1016/j.physbeh.2019.112572.

    PMID: 31175889
  16. 16

    Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.

    Donovan KA, An J, Nowak RP, et al.

    eLife 2018; (7()).

    PMID: 30067223
  17. 17

    Molecular Mechanisms of the Teratogenic Effects of Thalidomide.

    Asatsuma-Okumura T, Ito T, Handa H

    Pharmaceuticals (Basel, Switzerland) 2020; (13(5)) doi:10.3390/ph13050095.

    PMID: 32414180
  18. 18

    Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.

    Upputuri B, Pallapati MS, Tarwater P, Srikantam A

    PLoS neglected tropical diseases 2020; (14(10)):e0008678 doi:10.1371/journal.pntd.0008678.

    PMID: 33035210
  19. 19

    Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report.

    Ferreira-Filho ES, Bahamondes L, Duarte DC, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022; (38(1)):90-93 doi:10.1080/09513590.2021.1974380.

    PMID: 34486922
  20. 20

    Adverse events in patients with leprosy on treatment with thalidomide.

    Drummond PLM, Santos RMMD, Carvalho GO, Pádua CAM

    Revista da Sociedade Brasileira de Medicina Tropical 2019; (52()):e20180385 doi:10.1590/0037-8682-0385-2018.

    PMID: 30994805
  21. 21

    Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy.

    Kesserwani H

    Cureus 2021; (13(2)):e13140 doi:10.7759/cureus.13140.

    PMID: 33728154
  22. 22

    What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum.

    Bhat RM, Vaidya TP

    Indian dermatology online journal 2020; (11(4)):482-492 doi:10.4103/idoj.IDOJ_561_19.

    PMID: 32832433

This page provides educational information about leprosy reactions. It does not replace professional medical advice. Always contact your healthcare provider immediately if you experience sudden nerve weakness, fever, or painful skin changes.

Get notified when new evidence is published on Leprosy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.